Numazu, Japan

Takuji Sato

USPTO Granted Patents = 7 


 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 108(Granted Patents)


Location History:

  • Okazaki, JP (1991 - 1993)
  • Numazu, JP (2011 - 2015)

Company Filing History:


Years Active: 1991-2025

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Takuji Sato: Innovator in Pharmaceutical Conjugates

Introduction

Takuji Sato is a prominent inventor based in Numazu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative conjugates for therapeutic applications. With a total of 7 patents to his name, Sato's work is recognized for its potential impact on various diseases and disorders.

Latest Patents

Among his latest patents, Sato has developed phosphatidylserine-binding conjugates. These conjugates are capable of binding phosphatidylserine (PS) and toll-like receptors (TLRs), offering promising uses for the treatment of selected diseases, including cancer. Another notable patent is for an IDO/TDO inhibitor, which is a compound that can serve as a therapeutic agent for a range of conditions such as tumors, infectious diseases, neurodegenerative disorders, and autoimmune diseases.

Career Highlights

Throughout his career, Takuji Sato has worked with notable companies, including Canbas Co., Ltd. and Toray Industries, Inc. His expertise in pharmaceutical innovations has positioned him as a key figure in the industry, contributing to advancements that address critical health challenges.

Collaborations

Sato has collaborated with talented individuals in his field, including Takumi Kawabe and Sayaka Yamamoto. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in pharmaceuticals.

Conclusion

Takuji Sato's contributions to pharmaceutical innovations through his patents and collaborations highlight his role as a significant inventor in the industry. His work continues to pave the way for advancements in therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…